SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-15-000037
Filing Date
2015-08-06
Accepted
2015-08-06 10:39:31
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q033115.htm 10-Q 914066
2 ex12.htm EX-12 64007
3 exhibit31_1.htm EX-31 12950
4 exhibit31_2.htm EX-31 12921
5 exhibit32_1.htm EX-32 3365
6 exhibit32_2.htm EX-32 3299
  Complete submission text file 0001367644-15-000037.txt   4215765

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ebs-20150630.xsd EX-101.SCH 31017
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20150630_cal.xml EX-101.CAL 58628
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20150630_def.xml EX-101.DEF 128295
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20150630_lab.xml EX-101.LAB 452801
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20150630_pre.xml EX-101.PRE 262248
12 XBRL INSTANCE DOCUMENT ebs-20150630.xml EX-101.INS 776871
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 151031651
SIC: 2834 Pharmaceutical Preparations